Navigation Links
UGA study explains peaks and troughs of dengue epidemics

Scientists have long known that epidemics of dengue fever wax and wane over a period of several years, but they've never been quite sure why. With the incidence and range of the potentially deadly mosquito-borne illness increasing, understanding the factors that influence these epidemics has never been more important.

A new study by researchers at the University of Georgia suggests that a brief period of cross-immunity conferred by any one of the four viral strains, or serotypes, that cause dengue explains the timing of epidemics.

"We found that since about the mid 1980s, there's been a sequential replacement of the dominant serotype," said lead author Helen Wearing, a post-doctoral researcher at the UGA Institute of Ecology. "So, for example, one year serotype three is 60 percent of the cases and the next year serotype two is dominant and so on. Epidemics of individual serotypes recur every eight to 10 years, but, at the same time, if you look at all the data together, you see about an average three-year cycle with some seasonal component to it."

In addition to helping resolve a long-standing debate in public health, the study, published this week in the early online edition of the journal Proceedings of the National Academy of Sciences, gives researchers a framework that can be used to create models that predict dengue outbreaks in both space and time.

"It's a framework that highlights the key elements you need to take into account while developing a forecasting model," Wearing said. "Because if you were to build a forecasting model without understanding the trends in cross-immunity, you would not necessarily predict what we observe."

The researchers examined 30 years of data from the government of Thailand and from a Thai clinic that keeps what is widely regarded as the most comprehensive set of data on dengue. Southeast Asia has been a dengue hot spot since the 1950s, but the researchers note that their model applies t
'"/>

Source:University of Georgia


Page: 1 2 3

Related biology news :

1. Bioartificial kidney under study at MCG
2. W.M. Keck Foundation funds study of friendly microbes
3. Yellowstone microbes fueled by hydrogen, according to U. of Colorado study
4. Genome-wide mouse study yields link to human leukemia
5. Clam embryo study shows pollutant mixture adversely affects nerve cell development
6. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
7. Same mutation aided evolution in many fish species, Stanford study finds
8. Sequencing of marine bacterium will help study of cell communication
9. Genetically modified rice in China benefits farmers health, study finds
10. A new study examines how shared pathogens affect host populations
11. NYU study reveals how brains immune system fights viral encephalitis
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: UGA study explains peaks and troughs dengue epidemics

(Date:8/19/2015)... N.Y. , Aug. 19, 2015  VOXX ... that it has entered into a Definitive Agreement ... property, of iris authentication market leader EyeLock through ... VOXX will have a controlling interest in the ... subject to completion of due diligence.  Expanding on ...
(Date:8/12/2015)... As the digital payment services ... advanced biometrics technology is accelerating beyond expectations.  While the ... using their credit cards, the digital currency, mobile payment ... services led by companies in the space such as ... (NASDAQ: GOOG ), Apple Inc. (NASDAQ: AAPL ...
(Date:8/10/2015)... The latest 364 page report from business intelligence ... border security market . Visiongain assesses that ... Now: Border security is hard to achieve and harder ... issue you need to know about - and more importantly, ... how this will impact your company and the border security ...
Breaking Biology News(10 mins):VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 2VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 4VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 5Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 2Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 3Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 4Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 5Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 6Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 2Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 3Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 4Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 5Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 6Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 7Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 8Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 9
... University Hospital have discovered a new genetic disease that can ... the bile is missing, the liver cells are exposed to ... liver, a transformation of liver cells into connective tissue with ... of the cases of liver cirrhosis of unknown origin and ...
... Jewish Health have identified a simple gene-based blood test ... response to therapy than current tests. The test, a ... and help clear a backlog of promising medications now ... the results of a small "proof-of-principal" trial in the ...
... (OTC Bulletin,Board: CICI) Communication Intelligence Corporation ("CIC" ... solutions for,business process automation in the financial industry ... today its financial,results for the three and nine-month ... for the three months ended September 30, 2008 ...
Cached Biology News:Toxic bile damages the liver 2New test promises quicker, more accurate evaluation for cystic fibrosis patients 2New test promises quicker, more accurate evaluation for cystic fibrosis patients 3Communication Intelligence Corporation Reports Third Quarter 2008 Financial Results 2Communication Intelligence Corporation Reports Third Quarter 2008 Financial Results 3Communication Intelligence Corporation Reports Third Quarter 2008 Financial Results 4Communication Intelligence Corporation Reports Third Quarter 2008 Financial Results 5Communication Intelligence Corporation Reports Third Quarter 2008 Financial Results 6Communication Intelligence Corporation Reports Third Quarter 2008 Financial Results 7
(Date:9/3/2015)... ... September 03, 2015 , ... Michigan-based technology startup ... early 2016. , The device, called the Halo H1, is a wearable ... sensing technology. These sensors track trending interstitial fluid levels in the body, in ...
(Date:9/2/2015)... , Sept. 2, 2015 ... announced the addition of Jain PharmaBiotech,s new ... to their offering. ... pharmaceutical and biotechnology industries is anticipated. Nanotechnology ... drug development - from formulations for optimal ...
(Date:9/2/2015)... 2015 Research and ... of Jain PharmaBiotech,s new report "Biochips and ... their offering. This report is an ... applications. The report starts with a description of ... Technologies include array comparative genomic hybridization (CGH), copy ...
(Date:9/2/2015)... Research and Markets ( ... new report "Gene Therapy - Technologies, Markets and ... for gene therapy are difficult to estimate as there ... is marketed in China since ... 2014-2024. The estimates are based on epidemiology of diseases ...
Breaking Biology Technology:Technology Startup Halo Wearables to Unveil Non-Invasive Hydration Monitoring Device Early 2016 2Global Nanobiotechnology Applications, Markets and Companies Report 2015-2024 2Global Nanobiotechnology Applications, Markets and Companies Report 2015-2024 3Global Biochips and Microarrays Technologies, Markets and Companies Report 2015 with Market Size in 2014 and Projected Value for the Years 2019 and 2024 2Global Gene Therapy Market Study 2015-2024 - Technologies, Markets and Companies Analysis 2
... Kendle (Nasdaq: KNDL ), a ... several of its senior clinical development experts will ... Information Association (DIA) 47th Annual Meeting, June 19-23, ... topics, including the benefits of hybrid monitoring; finding ...
... Advanced Cell Technology, Inc. ("ACT"; OTCBB: ACTC), a ... the enrollment of the first patients in its two ... and Dry Age-Related Macular Degeneration (Dry AMD) using retinal ... cells (hESCs). The patients were enrolled at the Jules ...
... SEATTLE, June 16, 2011 Dendreon Corporation (Nasdaq: DNDN ... 26th Investor Program in London on June 21, 2011 at 9:30 ... webcast live and available for replay from Dendreon,s website, www.dendreon.com ... it will be archived on the site following the presentation. To ...
Cached Biology Technology:Kendle Experts to Address Key Industry Issues at Drug Information Association 47th Annual Meeting 2Kendle Experts to Address Key Industry Issues at Drug Information Association 47th Annual Meeting 3ACT Announces First Patients Enrolled in Two Clinical Trials Using Embryonic Stem Cells to Treat Stargardt's Disease and Dry Age-Related Macular Degeneration 2ACT Announces First Patients Enrolled in Two Clinical Trials Using Embryonic Stem Cells to Treat Stargardt's Disease and Dry Age-Related Macular Degeneration 3ACT Announces First Patients Enrolled in Two Clinical Trials Using Embryonic Stem Cells to Treat Stargardt's Disease and Dry Age-Related Macular Degeneration 4ACT Announces First Patients Enrolled in Two Clinical Trials Using Embryonic Stem Cells to Treat Stargardt's Disease and Dry Age-Related Macular Degeneration 5
Xanthine Oxidase (Bovine Buttermilk). Monospecific by IEP. Some cross reactivity with Xanthine Oxidase of other species and tissues may occur....
...
QPRT Immunogen: QPRT (NP_055113, 198 a.a. ~ 298 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
QPRT Immunogen: QPRT (NP_055113, 198 a.a. ~ 298 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Biology Products: